Chemours

Chemours

Preço: 22.00

Empresa e modelo de negócios

Chemours is a global leader in the materials sector, specializing in titanium technologies, fluoroproducts, and chemical solutions. Its core products include titanium dioxide, used in coatings and plastics, and fluorinated products for refrigeration and industrial applications. Major business segments encompass Titanium Technologies, Fluoroproducts, and Chemical Solutions, with revenue primarily derived from the sale of these materials to various industries, including automotive, construction, and electronics.

Perfil de investimento

The investment profile of Chemours suggests it may appeal more to value investors due to its current pricing relative to earnings and dividend yield. However, the stock's volatility and recent performance indicate higher risk, which may not align with conservative investment strategies. Investors should consider their risk tolerance and investment horizon when evaluating this stock.

Site oficial

Métricas fundamentais (experimental)

EPS (TTM) — lucro por ação dos últimos 12 meses, $
-2.73 Risco
Receita QoQ — crescimento da receita trimestre contra trimestre
3.8%
Surpresa de EPS
-63.4% pior que o esperado
Volatilidade 20d
3.4% estável
Dividend yield
2.0% moderado última data ex-dividendo: 2026-02-27
Dados FMP / FinFeed atualizados: 2026-06-13
Rec.: Vender Potencial: 37 Risco: 70 Atualizado: 2026-06-13 02:36
Como a recomendação funciona
Por que a IA pensa assim:
Weak fundamentals and high risk limit upside potential.

Acompanhar no portfólio

Gráfico de preço

Recomendação da IA Previsão do analista Evento de calendário Sinal positivo Sinal negativo Neutro / atualização Manter / informativo B My buy S My sell
Mudanças na recomendação da IA
Data Antes Depois Motivo
2026-06-05 02:33 Manter Vender scenario_deterioration
2026-06-01 02:33 Vender Manter Weak fundamentals and negative momentum raise significant concerns.
2026-05-08 15:27 Vender scenario_deterioration
Previsões de analistas
Data Analista Action Alvo Preço na época
2026-05-13 11:03 Alembic Global Preço-alvo elevado 24 → 30 24.67
2026-05-11 12:16 Morgan Stanley Preço-alvo elevado 17 → 21 24.45
2026-05-11 11:33 RBC Capital Preço-alvo elevado 26 → 29 23.04

Nada ainda